Oak Ridge Investments LLC Bristol Myers Squibb CO Transaction History

Oak Ridge Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $4.59 Million - $5.35 Million	-85,543 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $89,701 - $105,073	-1,516 Reduced 1.74%	85,543 $5.06 Million
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $96,393 - $104,972	-1,557 Reduced 1.76%	87,059 $5.82 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $51.4 Million - $57.8 Million	-866,238 Reduced 90.72%	88,616 $5.6 Million
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $51.4 Million - $57.8 Million	866,492 Added 980.62%	954,854 $60.3 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $1.97 Million - $2.23 Million	-34,088 Reduced 27.84%	88,362 $5.48 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $499,181 - $553,158	8,692 Added 7.64%	122,450 $7.38 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $68,196 - $79,727	-1,244 Reduced 1.08%	113,758 $6.69 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $5.34 Million - $7.75 Million	115,002 New	115,002 $6.41 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.